A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...
The Brighterside of News on MSN
New drug combination stops prostate cancer growth in phase 3 clinical trial
An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...
The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...
Patients with a certain form of aggressive prostate cancer could benefit from a new combination of drugs which slow cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback